- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Lantern Pharma Inc.
Headquarters: Dallas, TX, United States of America
Website: http://www.lanternpharma.com...
Year Founded: 2013
Status: Public
Industry Sector: HealthTechnology
CEO: Panna L. Sharma
Number Of Employees: 21
Enterprise Value: $5,337,121
PE Ratio: -2.11
Exchange/Ticker 1: NASDAQ:LTRN
Exchange/Ticker 2: N/A
Latest Market Cap: $40,334,800
BioCentury | May 7, 2024
Deals
Deals report: Novartis strengthens radiotherapy pipeline with pair of deals
Plus: Xyphos-Poseida to develop allogeneic CAR T therapies, Chiesi gains ex-U.S. right to Gossamer’s seralutinib, and more
BioCentury | Jan 18, 2024
Management Tracks
Paul stepping down as Karuna CSO
Plus: leadership changes at Valo and more from Mirum, Arvinas, Vaxcyte, Lantern and Inhibikase
BioCentury | Jul 23, 2021
Translation in Brief
DeepMind pops hood, opens trunk of its protein structure prediction tech
Plus: trio of COVID-19 therapies, Accure, Foresite and more
BioCentury | Jun 13, 2020
Finance
With nearly $1B raised overnight, quartet of offerings underscore demand for biotech IPOs
Avidity, Burning Rock, Generation Bio and Vaxcyte each raise over $200M, post gains of at least 30%
BioCentury | Jun 12, 2020
Finance
June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO
BioCentury | Jun 9, 2020
Finance
Next up on NASDAQ: trio of preclinical companies ready for debuts, plus new filings
BioCentury | Jun 3, 2020
Finance
Third Rock-launched Pliant is latest biotech to climb on public debut
Three more biotechs hope to price deals on NASDAQ this week
BioCentury | Jun 2, 2020
Finance
CAR T play Legend looks to lead trio of biotechs onto NASDAQ
Pliant, Lantern also hope to price IPOs this week
BioCentury | May 14, 2020
Finance
May 13 Quick Takes: MyoKardia raises $551M; plus Legend looks to NASDAQ for IPO and ADC, Travecta, QureBio, Kintor, Lantern, Kiromic
Items per page:
1 - 10 of 14